Cripe LD - Search Results

1

Cripe LD, Hromas R. Cripe LD, et al. Semin Hematol. 1998 Jul;35(3):200-9. Semin Hematol. 1998. PMID: 9685166 Review.

2

Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.

Abonour R, Scott KM, Kunkel LA, Robertson MJ, Hromas R, Graves V, Lazaridis EN, Cripe L, Gharpure V, Traycoff CM, Mills B, Srour EF, Cornetta K. Abonour R, et al. Bone Marrow Transplant. 1998 Nov;22(10):957-63. doi: 10.1038/sj.bmt.1701473. Bone Marrow Transplant. 1998. PMID: 9849692 Clinical Trial.

3

The exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors.

Hromas R, Cripe L, Hangoc G, Cooper S, Broxmeyer HE. Hromas R, et al. Blood. 2000 Feb 15;95(4):1506-8. Blood. 2000. PMID: 10666233 Free article.

4

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.

Nelson RP Jr, Yu M, Schwartz JE, Robertson MJ, Hromas R, Fausel CA, Vance GH, Dlouhy SR, Baute JA, Cox EA, Wood LL, Srivastava S, Robertson KA, Haut PR, Farag SS, Abonour R, Cornetta K, Cripe LD. Nelson RP Jr, et al. Among authors: cripe ld. Bone Marrow Transplant. 2010 Aug;45(8):1300-8. doi: 10.1038/bmt.2009.348. Epub 2010 Jan 11. Bone Marrow Transplant. 2010. PMID: 20062092

5

Adult acute leukemia.

Cripe LD. Cripe LD. Curr Probl Cancer. 1997 Jan-Feb;21(1):1-64. doi: 10.1016/s0147-0272(97)80006-2. Curr Probl Cancer. 1997. PMID: 9058027 Review.

6

Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.

Hartman AD, Wilson-Weekes A, Suvannasankha A, Burgess GS, Phillips CA, Hincher KJ, Cripe LD, Boswell HS. Hartman AD, et al. Among authors: cripe ld. Exp Hematol. 2006 Oct;34(10):1360-76. doi: 10.1016/j.exphem.2006.05.019. Exp Hematol. 2006. PMID: 16982329 Free article.

7

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.

Khawaja MR, Perkins SM, Schwartz JE, Robertson MJ, Kiel PJ, Sayar H, Cox EA, Vance GH, Farag SS, Cripe LD, Nelson RP Jr. Khawaja MR, et al. Among authors: cripe ld. Am J Hematol. 2015 Feb;90(2):97-9. doi: 10.1002/ajh.23875. Am J Hematol. 2015. PMID: 25345651 Free article.

8

Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience.

Sayar H, Bashardoust P, Cripe L, Chakraborty S, Bai S. Sayar H, et al. Am J Hematol. 2017 Feb;92(2):E17-E18. doi: 10.1002/ajh.24601. Epub 2016 Dec 7. Am J Hematol. 2017. PMID: 27813149 Free article. No abstract available.

9

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.

Gordon MS, Young ML, Tallman MS, Cripe LD, Bennett JM, Paietta E, Longo W, Gerad H, Mazza J, Rowe JM. Gordon MS, et al. Among authors: cripe ld. Leuk Res. 2000 Oct;24(10):871-5. doi: 10.1016/s0145-2126(00)00043-6. Leuk Res. 2000. PMID: 10996206 Clinical Trial.

10

Treating low-risk myelodysplastic syndromes in the community setting.

Cripe LD. Cripe LD. Clin Adv Hematol Oncol. 2008 Jun;6(6):418-20. Clin Adv Hematol Oncol. 2008. PMID: 18567986 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters